This inventor holds 1 USPTO granted patent and 1 published patent application, plus 2 CIPO patents and 1 EPO patent. Top assignee: G2gbio, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Heekyoung Choe: Innovator in Pharmaceutical Development
Introduction
Heekyoung Choe is a notable inventor based in Ansan, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug delivery systems. His work focuses on addressing critical health issues such as diabetes and neurodegenerative diseases.
Latest Patents
Heekyoung Choe holds 1 patent for a pharmaceutical composition that includes sustained-release microspheres containing a GLP-1 analogue or its pharmaceutically acceptable salt. This invention is particularly useful for the prevention and treatment of various conditions, including diabetes, high blood pressure, and obesity. The sustained-release microsphere technology allows for effective drug delivery while minimizing side effects, thereby improving patient comfort during administration.
Career Highlights
Choe's career is marked by his dedication to advancing pharmaceutical science. His innovative approach to drug formulation has the potential to transform treatment protocols for chronic diseases. He is currently associated with G2gbio, Inc., where he continues to develop groundbreaking solutions in the pharmaceutical industry.
Collaborations
Heekyoung Choe collaborates with talented professionals in his field, including Juhan Lee and Heeyong Lee. These partnerships enhance the research and development efforts at G2gbio, Inc., fostering an environment of innovation and creativity.
Conclusion
Heekyoung Choe's contributions to pharmaceutical innovation demonstrate his commitment to improving healthcare outcomes. His work in developing sustained-release drug formulations is paving the way for more effective treatments for chronic diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile